http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_214e51c6a5232d3cb130881ed262d7b2
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Bilhartz |
| name | David L. Bilhartz |
| given-name | David L. |
| organization-name | Center for Urological Treatment and Research, Nashville, Tennessee. From the Departments of Urology, Pathology, and Biochemistry & Molecular Biology, Mayo Clinic, Rochester, Minnesota; The Department of Cell Biology, Baylor College of Medicine, Houston, Texas From the Dana-Farber Cancer Institute, Harvard Medical School, Boston; Therion Biologics, Cambridge, MA; Trial Architecture Consulting, Washington, DC; University of Colorado, Aurora, CO; Urology Associates, Nashville, TN; Medical Oncology Branch and the Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD; and BN ImmunoTherapeutics, Mountain View, CA. From the Departments of Urology and Biostatistics, Mayo Clinic, Rochester, Minnesota From the Massachusetts General Hospital, Boston, MA; University of California at Los Angeles, Los Angeles; University of California at San Francisco, San Francisco; Western Clinical Research, Torrance, CA; University of Montreal, Montreal, Canada; University of Maryland, Baltimore, MD; S Florida Medical Research, Aventura, FL; Christchurch Hospital, Christchurch, New Zealand; Peter MacCallum Cancer Institute, Melbourne, Australia; Free University of Brussels, Brussels, Belgium; Novartis Oncology, East... Center for Urological Treatment and Research and Nashville Plastic Surgery, Nashville, Tennessee. |
Incoming Links
Total number of triples: 23.